Table 4. Risks of complications and mortality during stroke hospitalization associated with COPD and COPD exacerbations.
| No COPD | COPDne | COPDe | Risk of outcomes for COPDne | Risk of outcomes for COPDe | ||||
|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | OR (95% CI)c | OR (95% CI)c | |
| Number | 230553 | 38997 | 7924 | |||||
| Mortality | 7827 | (3.4) | 1373 | (3.5) | 344 | (4.3) | 1.14 (1.07–1.22) | 1.34 (1.20–1.52) |
| Epilepsy | 3786 | (1.6) | 798 | (2.1) | 192 | (2.4) | 1.27 (1.17–1.38) | 1.43 (1.22–1.67) |
| Pneumonia | 12877 | (5.6) | 3353 | (8.6) | 921 | (11.6) | 1.24 (1.18–1.29) | 1.50 (1.39–1.62) |
| Acute myocardial infarction | 1846 | (0.8) | 337 | (0.9) | 79 | (1.0) | 0.90 (0.80–1.02) | 0.92 (0.72–1.16) |
| Gastrointestinal bleeding | 5563 | (2.4) | 1087 | (2.8) | 245 | (3.1) | 0.98 (0.91–1.05) | 0.97 (0.85–1.11) |
| Urinary tract infection | 21071 | (9.1) | 4027 | (10.3) | 849 | (10.7) | 1.02 (0.98–1.06) | 1.06 (0.98–1.14) |
| Adverse eventsa | 22672 | (9.8) | 5051 | (13.0) | 1335 | (16.9) | 1.23 (1.19–1.28) | 1.55 (1.42–1.63) |
| Length of stay, daysb | 8.6±7.0 | 8.5±6.8 | 9.3±7.1 | 0.0048 | <0.0001 | |||
CI = confidence interval; COPD = chronic obstructive pulmonary disease; COPDe = chronic obstructive pulmonary disease exacerbations; OR = odds ratio.
a Adverse events include pneumonia, epilepsy and mortality
b Mean±SD
c Adjusted for all covariates listed in Table 3 except for respiratory medications.